Immediate Impact
1 by Nobel laureates 1 from Science/Nature 62 standout
Citing Papers
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
2024 Standout
Cancer therapy with antibodies
2024 Standout
Works of Peter Kießling being referenced
Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations
2020
The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Peter Kießling | 688 | 569 | 944 | 40 | 1.9k | |
| J C Brouet | 436 | 544 | 535 | 49 | 1.8k | |
| Carl Lenarsky | 867 | 309 | 438 | 53 | 1.9k | |
| Ann Traynor | 674 | 373 | 576 | 60 | 2.0k | |
| Robert Briddell | 929 | 328 | 522 | 38 | 1.7k | |
| Alessandra Stacchini | 493 | 633 | 629 | 76 | 1.9k | |
| Barbara Bigerna | 679 | 546 | 659 | 34 | 2.4k | |
| Ivana Pierri | 566 | 432 | 746 | 67 | 2.0k | |
| RG Andrews | 1517 | 448 | 885 | 32 | 2.5k | |
| Sylvain Fisson | 316 | 118 | 2061 | 49 | 2.9k | |
| Steven C. Ziesmer | 270 | 710 | 1523 | 65 | 3.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...